1 option
Advancing therapeutic development for dry age-related macular degeneration (AMD) / Lisa J. Bain, Sheena M. Posey Norris.
- Format:
- Book
- Author/Creator:
- Bain, Lisa J., author.
- Posey Norris, Sheena M., author.
- Language:
- English
- Subjects (All):
- Retinal degeneration--Age factors.
- Physical Description:
- 1 online resource (8 pages) : illustrations
- Other Title:
- Advancing therapeutic development for dry age-related macular degeneration
- Place of Publication:
- Washington, D. C. : the National Academies Press, 2015.
- Summary:
- Age-related macular degeneration (AMD) is the leading cause of blindness among white Americans and others of European descent, with lower prevalence among those of Asian, Latino, or African ancestry. The overall prevalence of AMD is approximately 8.7 percent worldwide and is expected to rise to 196 million people worldwide by 2020 and 288 million by 2040. AMD typically affects people age 50 and older, and the prevalence increases with age, particularly after the age of 75. In November 2014 the Institute of Medicine's Forum on Neuroscience and Nervous System Disorders hosted a workshop to discuss opportunities for advancing drug development for dry AMD. This report summarizes the presentation and discussion of that workshop.
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.